Fritextsökning
Innehållstyper
-
Suing the company – for NOT developing a new HIV drug
Was Gilead putting a steady flow of profits from its cash cow ahead of developing a new and safer drug? According to a large number of US HIV patients in a lega...
-
AstraZeneca moves to brewery quarters in central Copenhagen
AstraZeneca in Denmark is moving its business into central Copenhagen and the old brewery quarters in Carlsberg Byen.
-
Now it’s settled: The International Vaccine Institute will be located in Stockholm
The International Vaccine Institute, IVI, is establishing itself outside South Korea for the first time. Last week, the Swedish Parliament ratified the agreemen...
-
Samuel Lagercrantz: The government’s performance in healthcare and life sciences so far
Since the change of government in Sweden, developments in the healthcare sector have shown promising signs, but the outlook in life sciences is less promising, ...
-
Novavax is developing a vaccine candidate against Covid-19 and seasonal flu
A combined vaccine against both Covid-19 and seasonal flu is showing promising results in studies, according to the American drug developer Novavax. The adjuvan...
-
Life Science Sweden heads to the Oresund region! ‒ Hello there Michael Linnell
Life Science Sweden’s The Future of Swedish Danish Life Science and New Updates in Drug Formulation & Bioavailability meetings are coming up soon. We asked Mich...
-
Extremely high sample throughput rates
Precision and reliability in automated liquid handling
-
”Det finns inget trollspö” – stort behov av nya behandlingar
En av tio kvinnor med återkommande svampinfektion drabbas av ett svårbehandlat och långdraget tillstånd där det idag saknas effektiva behandlingar. Forskaren Ca...
-
Kraftsamling mot parkinson – svenska forskargrupper i samarbete
Fyra forskargrupper vid Karolinska institutet och Lunds universitet gör gemensam sak, men med parallella angreppssätt. Målet: att angripa grundorsakerna till Pa...
-
Rickard Sandberg on this year’s Nobel Prize in Medicine: ”A key discovery”
The discovery that paved the way for the development of todays mRNA vaccines is the basis for this year’s Nobel Prize in Physiology or Medicine.
-
The impact of the recession on the Swedish medtech sector
We need health care regardless of whether the economy is good or bad, but the current recession also affects the Medtech sector.
-
Här är de mest attraktiva arbetsplatserna när naturvetare får välja
Både läkemedelsföretag och universitet är några av de mest attraktiva arbetsgivarna inom life science-sektorn när naturvetare får välja. Det visar en ny undersö...
-
Uncertainty about the government’s life science work
The government’s national coordinator for life science, Jenni Nordborg, left her position almost four months ago. No one has yet succeeded her, and now question...
-
The new ZEISS Celldiscoverer 7 has been launched
Adaptable automation for advanced workflows.
-
Här är artiklarna som lästes mest i augusti
En amerikansk minister som kräver att studier han ogillar återkallas, globala nedskärningar hos två läkemedelsjättar och en myndighet som avböjer pressfrågor – ...
-
Comeback för plåster mot jordnötsallergi – lovande resultat i fas III
Franska DBV Technologies jordnötsallergiplåster Viaskin visar positiva resultat i en sen fas III-studie. Bolaget planerar nu en ny ansökan till amerikanska mynd...
-
Collaboration in laboratory automation
The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a resu...
-
The fast route to a safe insulin pen
Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...
-
“I am driven by the desire to develop a product that can be sold worldwide”
Ranked number one in the world by the WHO in diarrhoea research and soon in phase III studies for its vaccine candidate – Scandinavian Biopharma is rushing forw...
-
Varningen: Risker med Mysimba inte klarlagda
De långsiktiga kardiovaskulära riskerna med viktläkemedlet Mysimba är inte helt utredda. Därför införs nu rekommendationer till hälso- och sjukvården om årlig bedömning.
-
How critical are the “Spermageddon” reports? – Researchers call for action
A much talked about meta-study indicates that sperm concentration in men’s seminal fluid has halved in 40 years. Experts in andrology that Life Science Sweden s...
-
Setback for pharmaceutical companies in the Zantac case
A Delaware judge has ruled in favour of allowing expert witnesses to testify in a case involving the now-cancelled drug Zantac and its potential carcinogenicity.
-
The Swedish National Board of Health and Welfare rejects prioritising andrology as a speciality
Male infertility can be linked to a shorter lifespan and several severe diseases, but when couples who want children are examined, the focus is on the woman. Ex...
-
Per Alfredsson: ”Europa måste vara beredda att betala för innovativa mediciner”
Nu nalkas vinterns ledigheter. Det vill Life Science Sweden uppmärksamma genom att ställa bakåt- och framåtblickande frågor till bransch- och forskarprofiler fr...
BREAKING